Akut Miyeloid Lösemide Kromozomal Anomaliler:Tek Merkezden 417 Olgunun Sitogenetik Sonuçları

Yıl 2017, Cilt: 70 Sayı: 1, 37 - 51, 21.04.2017

Nüket Yürür Kutlay

https://doi.org/10.1501/Tipfak_0000000962

Öz

Amaç: Lösemi hastalarının tanısında ve izleminde sitogenetik belirteçlerin önemli rolü vardır. Lösemiler içinde akut miyelositer lösemi (AML) hastalarında, sitogenetik sonuçlar göreceli olarak daha karmașıktır. AML hastalarında 150’den fazla, yapısal ve sayısal, tekrarlayan kromozomal değișiklik bildirilmiștir. Geniș hasta serilerinin sitogenetik analiz sonuçlarının değerlendirilmesi, AML gelișimi konusundaki genetik bilgilerin artmasını, prognostik ya da diagnostik yeni belirteçler bulunmasını sağlayacaktır.

Gereç ve yöntem: Bu çalıșmada Ankara Üniversitesi Tıp Fakültesi Genetik Hastalıklar Tanı Merkezinde arșivlenen, AML tanılı 417 hastanın periferik kan/kemik iliği örneklerinden standart protokole uygun olarak yapılan hücre kültürlerinden elde edilen sitogenetik analiz sonuçları retrospektif olarak değerlendirilmiștir.

Bulgular: Bu serinin incelenmesi sonucunda, AML için bilinen; t(15;17), t(16;16), t(8;21), del11q, monozomi 7 ve trizomi 8 gibi yapısal ve sayısal değișikliklerin yanı sıra yeni bir delesyon ve 13 farklı kromozomal yeniden düzenlenme ilk olarak gösterilmiștir.

Sonuç: Çalıșmamızda tanımlı sayısal ve yapısal değișikliklerin dağılımı ile yeni bulunan kromozomal düzenlenmelerin AML gelișimi üzerine olabilecek etkileri tartıșılmıștır. Saptadığımız kırık noktaları çeșitli malignitelerde tanımlanan farklı yeni düzenlenmelerde daha önce raporlanmıștır. Ancak bu seride belirlenen değișikliklerde, farklı kombinasyonlar ve buna bağlı olarak önceden saptanmamıș gen füzyonlarının oluștuğu görülmektedir. Belirlenen kırık noktalarından bazılarında hematopoetik veya lenfoid doku maligniteleri ile ilișkilendirilmiș ya da olası ilișkili tanımlı genler bulunurken, bazılarında henüz bir gen tanımlanmamıștır. 

Anahtar Kelimeler

Akut Miyelositer Lösemi, AML

Kaynakça

• 1. De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J 2016 ;6:e441. doi: 10.1038/bcj.2016.50
• 2. Kansal R. Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification. Cancer Biol Med 2016;13: 41-54. doi: 10.28092/j.issn.20953941.2016.0001.
• 3. Atlas of Genetics and Cytogenetics in Oncology and Haematology. http://atlasgeneticsoncology.org/
• 4. National Cancer Instıtute. Cancer Genome Anatomy Project. Mitelman Database ofChromosome Aberations and Gene Fusions in Cancer. https://cgap.nci.nih.gov/Chromosomes/ AbnCytSearchForm
• 5. Czepulkowski B. Basic techniques for the preparation and analysis of chromosomesfrom bone marrowandleukemicblood. In: Rooney DE Ed. Human Cytogenetics Malignancy and Acquired Abnormalities. 3rd ed. Oxford: Oxford University Press, 2001. p:1-26.
• 6. Specchia G, Albano F, Anelli L, etal. Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints. Genes ChromosomesCancer. 2004 ;41(1):86-91.
• 7. Ogawa S, Yokoyama Y, Suzukawa K, etal. Identification of a fusion gene composed of a Hippo pathway gene MST2 and a common translocation partner ETV6 in a recurrent translocation t(8;12) (q22;p13) in acute myeloid leukemia. Ann Hematol. 2015; 94(8): 1431-3. doi: 10.1007/s00277015-2391-2. Epub 2015 May 3.
• 8. Meyer C, Hofmann J, Burmeister T, et al.The MLL recombinome of acute leukemias in 2013.Leukemia 2013; 27(11): 2165-76. doi: 10.1038/leu.2013.135. Epub 2013 Apr 30
• 9. Chapiro E, Russell L, Radford-Weiss I,et al. Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblasticleukemia. Blood 2006;108: 3560-3. Epub 2006 Jul 27.
• 10. Lin LI, Chen CY, Lin DT, et al. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells Clin Cancer Res. 2005;11:1372-9PMID 15746035
• 11. Bene MC, Castoldi G, Knapp W, et al. CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review. Leukemia. 2004;18: 394-400. (REVIEW) PMID 14671631
• 12. Brambillasca F, Mosna G, Colombo M, et al. Identification of a novel molecular partner of the E2A gene in childhood leukemia. Leukemia 1999;13: 369-75.
• 13.Akasaka T, Lossos IS, Levy R.BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 2003;102:1443-8. Epub 2003 May 8.
• 14. Kaparou M, Choumerianou D, Perdikogianni C, et al. Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features.GenetMol Biol. 2013; 36: 7-11. doi: 10.1590/S141547572013005000003. Epub 2013 Mar 4.
• 15. Duhoux FP, De Wilde S, Ameye G, et al. Novel variant form of t(11;22)(q23;q13)/MLL-EP300 fusion transcript in the evolution of an acute myeloid leukemia with myelodysplasiarelated changes. Leuk Res. 2011;35: e18 20. doi: 10.1016/j.leukres.2010.09.024. Epub 2010 Oct 25. PMID 20980053
• 16. Kitabayashi I, Aikawa Y, Yokoyama A, et al. Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation. Leukemia. 2001 Jan;15:89-94.PMID 11243405
• 17. Kim J, Park TS, Song J, et al. Detection of FUS-ERG chimeric transcript in two cases of acute myeloid leukemia with t(16;21)(p11.2;q22) with unusual characteristics. Cancer GenetCytogenet. 2009; 194:111-8. doi: 10.1016/j.cancergencyto.2009.06.010.
• 18. Wang J, Jani-Sait SN, Escalon EA, et al. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. Proc Natl Acad Sci U S A. 2000; 97: 3497-502.
• 19. Aplan PD, Johnson BE, Russell E, Chervinsky DS, Kirsch IR. Cloning and characterization of TCTA, a gene located at the site of a t(1;3) translocation. CancerRes. 1995; 55:1917-21.
• 20. Sano K, Hayakawa A, Piao JH, Kosaka Y, Nakamura H.Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapyrelated leukemia with t(3;11)(p21;q23). Blood. 2000 Feb 1;95:1066-8.
• 21.Murga Penas EM, Kawadler H, Siebert R, et al. .A novel fusion of the MALT1 gene and the microtubule-associated protein 4 (MAP4) gene occurs in diffuse large Bcell lymphoma. Genes Chromosomes Cancer. 2006 Sep;45:863-73.
• 22. Dadi HK, Roifman CM. Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor on human thymocytes J Clin Invest. 1993 Sep;92: 1559-63.
• 23. Hunger SP. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood. 1996; 87:1211-24.
• 24. Homminga I, Vuerhard MJ, Langerak AW, et al. Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements. Haematologica. 2012; 97: 258-61. doi: 10.3324/haematol.2011.051722. Epub 2011 Nov 4.
• 25. Tirado CA, Lager J, Rosoff PM, et al. A case of infantile acute lymphoblastic leukemia presenting with rearrangement of MLL at 11q23 and apparent insertion or translocation at 10p12. Cancer Genet Cytogenet. 2004; 154: 57-9
• 26. Taki T, Shibuya N, Taniwaki M, et al. ABI-1, a human homolog to mouse Ablinteractor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23). Blood 1998; 92:112530.
• 27. Ito K, Bernardi R, Morotti A, et al. PML targeting eradicates quiescent leukaemiainitiating cells. Nature. 2008 Jun 19;453(7198):1072-8. doi: 10.1038/nature07016. Epub 2008 May 11.
• 28. Matutes E, Carrara P, Coignet L, et al. FISH analysis for BCL-1 rearrangements and trisomy 12 helps the diagnosis of atypical B cell leukaemias. Leukemia 1999; 13: 1721-6.
• 29.Wells RA, Catzavelos C, Kamel-Reid S. Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nature genetics. 1997 ; 17 (1) : 109-113
• 30. Imagama S, Abe A, Suzuki M, et al. .LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22). Eur J Haematol. 2007; 79: 25-31. Epub 2007 May 28
• 31. Gruber TA, Larson Gedman A, Zhang J, et al. An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. Cancer Cell. 2012; 22: 683-97. doi:10.1016/j.ccr.2012.10.007.
• 32. Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012; 22:153-66. doi: 10.1016/j.ccr.2012.06.005.
• 33. Baxter EJ, Kulkarni S, Vizmanos JL, et al. Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABLnegative chronic myeloproliferative disorders. Br J Haematol. 2003;120:251-6.
• 34. Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A. Novel t(5;9) (q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006; 20: 313-8.
• 35. Ernst T, Score J, Deininger M, et al. Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia. Br J Haematol. 2011;153(1): 43-6. doi: 10.1111/j.13652141.2010.08457.x. Epub 2011 Feb 1.
• 36. Chaffanet M, Mozziconacci MJ, Fernandez F, et al. A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16). GenesChromosomes Cancer 1999; 26: 161-5.
• 37. Murati A, Adélaïde J, Mozziconacci MJ, et al. Variant MYST4-CBP gene fusion in a t(10;16) acute myeloid leukaemia. British journal of haematology. 2004; 125: 601-604.
• 38. Steidl C, Shah SP, Woolcock BW, et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 2011; 471(7338): 377-81. doi: 10.1038/nature09754. Epub 2011 Mar 2.
• 39 .Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 1999 ; 93: 3167-3215
• 40. Gu G, Sederberg MC, Drachenberg MR, South ST.IGF2BP1: a novel IGH translocation partner in B acute lymphoblastic leukemia. Cancer Genet 2014; 207: 332-4. doi: 10.1016/j.cancergen. 2014.07.002. Epub 2014 Jul 23